Related Tags >> vaccine Cervarix Jean Stéphenne PATH Malaria Vaccine Initiative

GlaxoSmithKline News

Most Popular GlaxoSmithKline Story

Glaxo snags Alzheimer's vax rights in €452.5M deal

October 23, 2008 — 8:05am ET | By John Carroll

GlaxoSmithKline has put down €22.5 million and promised up to €430 million more to license the rights to two early-stage Alzheimer's disease vaccines from Austria's AFFiRiS. Glaxo picks up... Read more...

GlaxoSmithKline Press Releases

GSK statement on Avandia study approach presented at American Heart Association Scientific Sessions 2008
GSK Major Seasonal Influenza Vaccine Efficacy Trial To Assess Superior Protection For Those At Risk Of Influenza
GSK and XenoPort Announce Plans to Withdraw and Resubmit New Drug Application Requesting Approval of Solzira for Restless Leg
URCH Publishing: GlaxoSmithKline Will Overtake Pfizer to Become World's Largest Pharmaceutical Company by 2012
GSK Believes There Is No Liver Safety Issue With AVANDIA; Responds to Public Citizen Petition

Latest Headlines

Glaxo wins European contract for Cervarix
November 20, 2008
GSK kickstarts global trial for seasonal flu vax
November 10, 2008
Glaxo snags Alzheimer's vax rights in €452.5M deal
October 23, 2008
Combo vaccines endorsed by federal advisory panel
July 3, 2008
Glaxo ready to wait for late-stage Cervarix data
July 3, 2008
Glaxo touts effectiveness of pediatric vaccine candidate
June 12, 2008
Cervarix data demonstrates prolonged protection
May 15, 2008
GSK bird flu vaccine provides more positive data
March 6, 2008
GSK's secret vaccine adjuvant draws attention
February 28, 2008

Paid Research Reports